about
Inter-individual variability in response to clopidogrel in patients with coronary artery diseaseMore aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservativelyEffects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndromeBorderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.No long-term clinical benefit from manual aspiration thrombectomy in ST-elevation myocardial infarction patients. Data from NRDES registry.The impact of multiple stent implantation in the infarct-related artery on one-year clinical outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Data from the Polish NRDES Registry.Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry.Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.Complete infarct-related artery revascularization in acute myocardial infarction patients. CORAMI RegistryTransradial percutaneous coronary intervention for unprotected left main closure during acute myocardial infarction.Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry.Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionNo clinical benefit from manual thrombus aspiration in patients with non-ST-elevation myocardial infarctionPredictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-upPatient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014-2015.Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.Impact of Coronary Artery Disease Burden on 12-Month Mortality of Patients After Transcatheter Aortic Valve Implantation.Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention.Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement.Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland.Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock.The successful retrieval of a broken guide wire from the diagonal branch of the left anterior descending coronary artery complicated by partial stent rolling.Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation.Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.Time delay in primary angioplasty: how relevant is it?Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.Relationship between chronic obstructive pulmonary disease and in-hospital management and outcomes in patients with acute myocardial infarction.Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention.Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction.Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Małopolska Registry of Acute Coronary Syndromes 2005Percutaneous peripheral interventions in patients with multivessel coronary artery disease.[Invasive treatment strategies in patients with myocardial infarction in Poland].Patient with non-ST-segment elevation myocardial infarction treated by Absorb bioresorbable scaffold implantation.Acute myocardial infarction in a patient with chronic renal failure and endocarditis.Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry.Primary percutaneous coronary intervention during on- vs off-hours in patients with ST-elevation myocardial infarction. Results from EUROTRANSFER Registry.Acute left main occlusion during transcatheter aortic valve implantation.Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively.Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry).
P50
Q28173909-0A11C70F-E462-4967-9D5A-92020D24C782Q28210384-9B27DB13-1C24-4175-8DAA-8011DCA09188Q28213880-24B445C8-DC82-4461-9D7E-447C4BDBE85EQ30667055-9175678D-0517-4EFF-B771-336193734B06Q30829790-6DB8EDFA-879F-4EA7-837C-01E3EA937A19Q31048057-F293ACAD-4F72-47C7-8F22-082B831722C4Q33475333-9CFC806E-7964-46E1-9E5E-BD61BDCFE648Q33572740-053CDC29-8B52-4CCD-88B7-7E47F5B07BE8Q35829145-4A41071C-C425-4679-B566-F7C82DB29C8DQ35829176-8BA85A50-744E-4EFF-8451-44C200F5AF15Q36046152-02D09FA3-37C1-430E-B385-432494A1A42DQ36281977-2BF28D94-26B7-4C56-9523-B19F1FAC9FF2Q36649939-59729BE7-E255-4227-A240-E6D3522B3BB7Q37259852-550B4B77-4703-4851-BF72-5C78EC7BB4A7Q37463810-7B0B3958-AF61-499B-AB0D-1B92A05BC526Q38417563-4FD116A6-1B7B-4DA3-AA2D-4CEDA7C798B4Q39643974-150D2DA6-FD9A-4579-B1CA-4C631ECBFDD8Q39748661-61A61D95-B7D5-4357-B68A-3C0550C78ACEQ40072501-3836AE15-36C8-49E8-BF5A-C6439A108E54Q41016389-757DBF61-C275-4D72-AFF1-56668D8E5D17Q41712723-376E21B9-904F-44B7-BE83-965405579C44Q42175790-E9AB94B5-308F-40B1-AD74-F70325E6ED78Q42360034-F48399EB-B9DC-4E3C-87AD-5AFE8F2E7717Q42384141-75C346AD-EFCE-4317-B212-29E65BDFC08EQ42539167-DC732F1A-984B-4754-9024-12590F0E1AD1Q43066959-94B6A81E-C493-49CD-B2A7-647F183B1A51Q43089338-82533A67-EF1C-4BE1-974C-51D8FDAA34AFQ43107574-18027483-628A-409D-86B5-3083F92B02C2Q43466558-D568B7EF-D6E2-4AF5-9A9B-6D8F5F359AF4Q43543070-9C4096A9-1A3B-45A9-9F35-70604ED26E92Q43645943-498CF05F-34BA-490E-A6E0-17D445263B70Q43711323-7ED0BCD3-1B91-4E40-B2FC-0EBC7495FB7AQ43770275-408F28D9-9DEB-4B2A-82C4-8FD38D0EA797Q43978532-1A30DB0E-1E93-4BBE-8810-51DB61999197Q44152225-3B5B498C-71A2-463E-90E7-FB838230EE69Q45062855-0EC29C5A-1FA8-4F70-9ADC-DF207453FB47Q45729393-50DCF590-4D2A-4B82-99BD-DDA6D8429D82Q45858910-0EA56437-F407-4D17-A61F-B19F590A63F9Q46071514-BCB18F1A-4BE5-4A31-A4D0-8FE0CC9FF1D7Q46131284-437F9185-93E3-4AE6-923F-60067F27F175
P50
description
Polish cardiologist
@en
Pools onderzoeker
@nl
polski kardiolog
@pl
հետազոտող
@hy
name
Artur Dziewierz
@ast
Artur Dziewierz
@ca
Artur Dziewierz
@cs
Artur Dziewierz
@en
Artur Dziewierz
@es
Artur Dziewierz
@ga
Artur Dziewierz
@gl
Artur Dziewierz
@hr
Artur Dziewierz
@hsb
Artur Dziewierz
@it
type
label
Artur Dziewierz
@ast
Artur Dziewierz
@ca
Artur Dziewierz
@cs
Artur Dziewierz
@en
Artur Dziewierz
@es
Artur Dziewierz
@ga
Artur Dziewierz
@gl
Artur Dziewierz
@hr
Artur Dziewierz
@hsb
Artur Dziewierz
@it
prefLabel
Artur Dziewierz
@ast
Artur Dziewierz
@ca
Artur Dziewierz
@cs
Artur Dziewierz
@en
Artur Dziewierz
@es
Artur Dziewierz
@ga
Artur Dziewierz
@gl
Artur Dziewierz
@hr
Artur Dziewierz
@hsb
Artur Dziewierz
@it
P214
P106
P1153
6506220215
P1412
P1559
Artur Dziewierz
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-2100-5076
P735
P7859
viaf-313524429